A detailed history of Northern Trust Corp transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 255,134 shares of SCPH stock, worth $862,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares
255,134
Previous 247,922 2.91%
Holding current value
$862,352
Previous $1.08 Million 7.88%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.12 - $5.51 $29,713 - $39,738
7,212 Added 2.91%
255,134 $1.16 Million
Q2 2024

Aug 14, 2024

SELL
$3.51 - $5.21 $59,273 - $87,981
-16,887 Reduced 6.38%
247,922 $1.08 Million
Q1 2024

May 14, 2024

SELL
$4.86 - $6.39 $20,543 - $27,010
-4,227 Reduced 1.57%
264,809 $1.33 Million
Q4 2023

Feb 13, 2024

BUY
$4.7 - $6.63 $263 - $371
56 Added 0.02%
269,036 $1.69 Million
Q3 2023

Nov 13, 2023

BUY
$7.0 - $9.82 $68,621 - $96,265
9,803 Added 3.78%
268,980 $1.92 Million
Q2 2023

Aug 11, 2023

BUY
$8.94 - $11.74 $1.75 Million - $2.3 Million
195,525 Added 307.18%
259,177 $2.64 Million
Q1 2023

May 15, 2023

BUY
$5.59 - $9.47 $80,121 - $135,733
14,333 Added 29.06%
63,652 $577,000
Q4 2022

Feb 13, 2023

SELL
$4.02 - $7.53 $1,061 - $1,987
-264 Reduced 0.53%
49,319 $353,000
Q3 2022

Nov 14, 2022

BUY
$4.48 - $6.52 $6,616 - $9,630
1,477 Added 3.07%
49,583 $323,000
Q2 2022

Aug 12, 2022

SELL
$4.3 - $6.48 $3,448 - $5,196
-802 Reduced 1.64%
48,106 $232,000
Q1 2022

May 13, 2022

SELL
$3.9 - $6.11 $3,127 - $4,900
-802 Reduced 1.61%
48,908 $278,000
Q4 2021

Feb 08, 2022

SELL
$3.88 - $6.9 $1,552 - $2,760
-400 Reduced 0.8%
49,710 $249,000
Q3 2021

Nov 15, 2021

BUY
$4.93 - $7.15 $1,109 - $1,608
225 Added 0.45%
50,110 $333,000
Q2 2021

Aug 13, 2021

SELL
$5.19 - $7.38 $337,287 - $479,611
-64,988 Reduced 56.57%
49,885 $305,000
Q1 2021

May 12, 2021

SELL
$5.65 - $7.66 $138,334 - $187,547
-24,484 Reduced 17.57%
114,873 $764,000
Q4 2020

Feb 11, 2021

SELL
$5.17 - $9.41 $33,594 - $61,146
-6,498 Reduced 4.46%
139,357 $737,000
Q3 2020

Nov 16, 2020

BUY
$7.12 - $8.86 $264,700 - $329,388
37,177 Added 34.21%
145,855 $1.09 Million
Q2 2020

Aug 14, 2020

BUY
$7.01 - $10.96 $761,832 - $1.19 Million
108,678 New
108,678 $799,000
Q4 2019

Feb 14, 2020

SELL
$4.1 - $6.21 $42,746 - $64,745
-10,426 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$3.24 - $7.35 $181,906 - $412,658
-56,144 Reduced 84.34%
10,426 $62,000
Q2 2019

Aug 13, 2019

SELL
$2.48 - $3.76 $5,190 - $7,869
-2,093 Reduced 3.05%
66,570 $213,000
Q1 2019

May 13, 2019

SELL
$2.84 - $4.18 $712 - $1,049
-251 Reduced 0.36%
68,663 $206,000
Q4 2018

Feb 12, 2019

BUY
$3.76 - $5.61 $308 - $460
82 Added 0.12%
68,914 $259,000
Q3 2018

Nov 14, 2018

BUY
$4.22 - $6.03 $3,798 - $5,427
900 Added 1.32%
68,832 $404,000
Q2 2018

Aug 14, 2018

BUY
$5.53 - $15.4 $110,306 - $307,183
19,947 Added 41.57%
67,932 $384,000
Q1 2018

May 09, 2018

BUY
$11.62 - $17.32 $557,585 - $831,100
47,985 New
47,985 $595,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $92.6M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.